AIP
BIIB icon

Almanack Investment Partners’s Biogen BIIB Stock Holding History

Almanack Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18
Closed -$5K – 285
2022
Q3 		$5K Buy
+18
New +$3.82K ﹤0.01% 571
2020
Q4 		– Sell
-1,210
Closed -$286K – 401
2020
Q3 		$286K Sell
1,210
-56
-4% -$15.6K 0.04% 301
2020
Q2 		$339K Buy
1,266
+56
+5% +$16.8K 0.06% 171
2020
Q1 		$383K Buy
+1,210
New +$367K 0.08% 153

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Almanack Investment Partners's BIIB Position: Q4 2022 in Review

Almanack Investment Partners sold out of Biogen (BIIB) in Q4 2022, closing a stake of 18 shares — an estimated $5K sold.

Almanack Investment Partners first reported a position in BIIB in Q1 2020 and held it in 4 quarters. The position peaked at $383K in Q1 2020. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Almanack Investment Partners reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 18 Biogen shares in Q4 2022, an estimated $5K.
  • Almanack Investment Partners first reported a position in Biogen in Q1 2020 and held it in 4 quarters.
  • Almanack Investment Partners's Biogen position peaked at $383K in Q1 2020.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.